Dr. Ruberti is a Distinguished Professor and Founder of the Bioengineering Department at Northeastern University. He is also the CEO of BrillantStrings Therapeutics. He obtained his doctoral degree (1998) in Biomedical Engineering from Tulane University, and conducted postdoctoral research at the Massachusetts Institute of Technology and at the Department of Biomedical Engineering, Northwestern University. He was an associate consultant at Cambridge Polymer Group, a Lecturer at the Massachusetts Eye and Ear Infirmary at Harvard University, and an Adjunct Assistant Scientist of the Schepen’s Eye Research Institute. He has produced ~70 scientific papers, reviews and book chapters, as well as over 100 conference presentations. His research has resulted in the issuance of 20 US and PCT patents, and the pending issuance of four more. He has received a total of $10.0 M in grants from the National Science Foundation (NSF), the Department of Defense, and the National Institutes of Health (NIH). He has served as a reviewer for the NIH and the NSF, and as a reviewer for many scientific journals in the areas of ophthalmology, materials, biomechanical engineering, biophysics, and cell and tissue engineering. He is also a fellow of the American Institute of Medical and Biological Engineers.